Clinical and Economic Outcomes of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Post-Bundling Era

RATIONALE & OBJECTIVE: Since the change in erythropoiesis-stimulating agent (ESA) labeling and bundling of dialysis services in the United States, few studies have addressed the clinical importance of ESA hyporesponsiveness and none have considered health care resource use in this population. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Cizman, Borut, Smith, Helen T., Camejo, Rodrigo Refoios, Casillas, Linda, Dhillon, Harjeet, Mu, Fan, Wu, Eric, Xie, Jipan, Zuckerman, Peter, Coyne, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568064/
https://www.ncbi.nlm.nih.gov/pubmed/33089137
http://dx.doi.org/10.1016/j.xkme.2020.06.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568064/
https://www.ncbi.nlm.nih.gov/pubmed/33089137
http://dx.doi.org/10.1016/j.xkme.2020.06.008

Ejemplares similares